Crawfordsville startup CorVus fattens pigs for science
The newly built farm uses a high-fat, high-cholesterol diet to give animals heart disease and diabetes to help medical researchers find treatments.
The newly built farm uses a high-fat, high-cholesterol diet to give animals heart disease and diabetes to help medical researchers find treatments.
A five-year, $7 million program is led and supported by a coalition of local health institutions, including Eli Lilly and Co., Fairbanks School of Public Health and Eskenazi Health. It is based on a model that Lilly has used in other countries.
The Indianapolis-based drugmaker has several pain medications in the pipeline, including potential treatments for migraine headaches, arthritis and chronic back pain.
A looming shortage of certified nurse aides is prompting Indiana’s nursing home industry and Ivy Tech Community College to develop a career pathway with more money for traditionally low-paid workers.
Health and Human Services Secretary Alex Azar, a former Eli Lilly and Co. executive who was hospitalized twice this week, has hired Jim Parker, president and CEO of MDwise and a former longtime executive at Anthem Inc.
For more than a decade, Zeke Turner built scores of senior-care facilities. But in the past year, Mainstreet has been reeling from an unexpected slowdown in sales of its properties.
Jonathan Nalli has a message for his 16,000 employees at St. Vincent Health: Get ready for more transformation and disruption.
The Indianapolis-based health system says it wants to give patients and consumers a chance to tell them what’s wrong with health-care delivery, and how to improve it.
The Indianapolis-based health system will present details Tuesday to the Carmel Plan Commission for the two-story, 88,000-square-foot building.
Officials say the expansion will help the hospital meet growing demand. Last year, it turned away 36 children for lack of a bed.
But Jonathan Nalli said the health system has no plans to build a $1 billion hospital complex.
Brian Holzhausen, 46, has run hundreds of races, from short blasts to 31-mile ultramarathons on rugged dirt trails. Following his passion, he jumped from a career in engineering to outdoor fitness.
By the end of the year, officials expect to unveil its master plan to remake the state’s largest hospital—currently an amalgamation of ancient health care amenities and modern facilities.
Under the agreement, Lilly will pay Sigilon Therapeutics up to $410 million if the technology hits certain milestones.
The Indianapolis-based insurer is telling members that those small, freestanding hospitals are out of its network and could be much costlier to use.
The industry’s payroll and average wages dipped last year, according the latest report from Indiana University and BioCrossroads.
A $44 million VC infusion in 2017 for biosciences firm On Target Laboratories was one indication that Indiana’s life sciences sector is finally starting to pull down some serious venture funding.
The 30-acre first phase of the 16 Tech innovation district, long touted as an up-and-coming hub for entrepreneurship and innovation, will be spurred by a $120 million investment from Browning and a $38 million grant from Lilly Endowment.
More than 100 people gathered Tuesday to plan how to oppose the project, which calls for nine buildings, two helipads and four parking garages.
Derica Rice, 53, one of the nation’s most powerful black executives, retired from Indianapolis-based drugmaker Eli Lilly and Co. in December, after the company passed him over when naming a new CEO.